These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 1991361)
21. Usefulness of the severity and extent of reversible perfusion defects during thallium-dipyridamole imaging for cardiac risk assessment before noncardiac surgery. Lette J; Waters D; Lapointe J; Gagnon A; Picard M; Cerino M; Kerouac M Am J Cardiol; 1989 Aug; 64(5):276-81. PubMed ID: 2756871 [TBL] [Abstract][Full Text] [Related]
22. [Dipyridamole-201thallium perfusion scintigraphy in coronary diseases]. Nienaber CA; Spielmann RP Dtsch Med Wochenschr; 1988 Jun; 113(25):1029-33. PubMed ID: 3289878 [No Abstract] [Full Text] [Related]
24. A look at 15 years of planar thallium-201 imaging. Kaul S Am Heart J; 1989 Sep; 118(3):581-601. PubMed ID: 2672756 [TBL] [Abstract][Full Text] [Related]
25. Efficacy of intravenous dipyridamole with exercise in thallium-201 myocardial perfusion scintigraphy. Laarman GJ; Bruschke AV; Verzijlbergen FJ; Bal ET; van der Wall EE; Ascoop CA Eur Heart J; 1988 Nov; 9(11):1206-14. PubMed ID: 3234412 [TBL] [Abstract][Full Text] [Related]
26. Perfusion imaging in ischemic heart disease. Rivitz SM; Deluca SA Am Fam Physician; 1993 Nov; 48(6):1071-8. PubMed ID: 8237730 [TBL] [Abstract][Full Text] [Related]
28. Hemodynamic indices of myocardial dysfunction correlate with dipyridamole thallium-201 SPECT. Chin BB; Moshin J; Bouchard M; Berlin JA; Araujo LI; Alavi A J Nucl Med; 1996 May; 37(5):723-9. PubMed ID: 8965134 [TBL] [Abstract][Full Text] [Related]
29. [Myocardial gammagraphy with thallium-201 and low-doses dipyridamole. Prediction of coronary lesions from segmental defects in perfusion]. Martínez Martínez A; Sánchez A; Ramos A; Latre JM; Fournier JA; Errazquin F; Burgos J Rev Esp Cardiol; 1987; 40(3):169-74. PubMed ID: 3628911 [No Abstract] [Full Text] [Related]
30. [The 3-year prognosis of patients with suspected coronary disease and a normal myocardial scintigraphy with thallium-dipyridamole]. Trabulo M; Gil V; Sousa L; Cunha R; Ferreira J; Ventosa A; Calqueiro J; Seabra-Gomes R Rev Port Cardiol; 1996 Mar; 15(3):211-5, 181. PubMed ID: 8634169 [TBL] [Abstract][Full Text] [Related]
31. [Myocardial 201T1 perfusion scintigraphy with the exercise test and/or with dipyridamole in the diagnosis of ischemic cardiopathies]. Picozzi R; Palagi B; Roda L; Tarolo GL Radiol Med; 1980 Nov; 66(11):828-30. PubMed ID: 7221050 [No Abstract] [Full Text] [Related]
32. Comparison of accuracy for detecting coronary artery disease and side-effect profile of dipyridamole thallium-201 myocardial perfusion imaging in women versus men. Kong BA; Shaw L; Miller DD; Chaitman BR Am J Cardiol; 1992 Jul; 70(2):168-73. PubMed ID: 1626502 [TBL] [Abstract][Full Text] [Related]
33. Dipyridamole combined with exercise for thallium-201 myocardial imaging. Walker PR; James MA; Wilde RP; Wood CH; Rees JR Br Heart J; 1986 Apr; 55(4):321-9. PubMed ID: 3964497 [TBL] [Abstract][Full Text] [Related]
34. Dipyridamole/thallium-201 imaging: how safe is it? When should it be used? Kaul S; Villanueva FS J Nucl Med; 1991 Nov; 32(11):2115-7. PubMed ID: 1941147 [No Abstract] [Full Text] [Related]
35. [Quantitative thallium myocardial tomoscintigraphy. Value of intravenous infusion of dipyridamole after negative submaximal exercise test]. Levy M; Pornin M; Languillat N; Charles JP; Angelard T; Sarkhis A; Bayet G; Guize L; Paillard M; Ourbak P Arch Mal Coeur Vaiss; 1992 Feb; 85(2):187-91. PubMed ID: 1562221 [TBL] [Abstract][Full Text] [Related]